|
RNF219 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.25215418431435E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.55815377162116E-12 |
| Normal-vs-Stage2 |
2.2055999999937E-05 |
| Normal-vs-Stage3 |
3.29189999703772E-08 |
| Normal-vs-Stage4 |
3.33509999950188E-07 |
| Stage1-vs-Stage2 |
8.322000E-01 |
| Stage1-vs-Stage3 |
8.487800E-01 |
| Stage1-vs-Stage4 |
3.645200E-01 |
| Stage2-vs-Stage3 |
7.697400E-01 |
| Stage2-vs-Stage4 |
4.462200E-01 |
| Stage3-vs-Stage4 |
5.388000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.39332989590457E-13 |
| Normal-vs-AfricanAmerican |
1.557140E-03 |
| Normal-vs-Asian |
3.521700E-03 |
| Caucasian-vs-AfricanAmerican |
2.107700E-02 |
| Caucasian-vs-Asian |
9.610200E-01 |
| AfricanAmerican-vs-Asian |
3.061000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.45190542816454E-11 |
| Normal-vs-Female |
2.1085355683681E-12 |
| Male-vs-Female |
1.354200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.618530E-04 |
| Normal-vs-Age(41-60Yrs) |
7.07778280428784E-12 |
| Normal-vs-Age(61-80Yrs) |
8.70914451667204E-12 |
| Normal-vs-Age(81-100Yrs) |
1.048370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.310800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.952200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.885600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.146800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.620020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.767590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.65159999999864E-05 |
| Normal-vs-Grade 2 |
1.64812608005604E-12 |
| Normal-vs-Grade 3 |
1.66110014632181E-10 |
| Normal-vs-Grade 4 |
2.983200E-04 |
| Grade 1-vs-Grade 2 |
7.998800E-01 |
| Grade 1-vs-Grade 3 |
4.878400E-01 |
| Grade 1-vs-Grade 4 |
4.486500E-02 |
| Grade 2-vs-Grade 3 |
2.971600E-02 |
| Grade 2-vs-Grade 4 |
5.73769999999696E-05 |
| Grade 3-vs-Grade 4 |
1.743930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.15160000002668E-06 |
| ccA subtype-vs-ccB subtype |
3.76270000002066E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.01347835574006E-12 |
| Normal-vs-N1 |
7.275500E-03 |
| N0-vs-N1 |
3.869400E-01 |
|
|
